
Sita-Glutaryl DM Tablet ER
Marketer
Vakula Health Care Private Limited
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg)
Overview Sita-Glutaryl DM Tablet ER
Gluco-Glutaryl ER tablets are a dual-action medication designed to manage blood glucose levels. This medication complements a healthy diet and exercise regimen to enhance blood sugar control in adult patients with type 2 diabetes. It facilitates efficient insulin use, resulting in lower blood sugar. Gluco-Glutaryl ER can be administered with or without food, but consistent daily timing is recommended. Dosage should be determined by your physician; discontinuation without medical guidance is strongly discouraged, as it may lead to elevated blood sugar and increased risk of severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment strategy that includes dietary modifications, regular physical activity, and weight management as directed by your doctor. Commonly reported side effects include upper respiratory infections, nasal stuffiness, throat irritation, and urinary tract infections. Adequate hydration is crucial to minimize dehydration. Genital yeast infections are a potential side effect, mitigated by diligent hygiene practices. Prior to commencing Gluco-Glutaryl ER therapy, inform your doctor of any existing kidney or liver conditions, urinary tract infections, or diuretic use. Pregnant or lactating women should seek medical consultation before use. Limit alcohol consumption while taking this medication to reduce the likelihood of adverse events. Regular blood glucose monitoring is essential during treatment.
Uses of Sita-Glutaryl DM Tablet ER
Managing Type 2 Diabetes
Major Benefits of Sita-Glutaryl DM Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sita-Glutaryl DM Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended for optimal results.
Common Side effects of Sita-Glutaryl DM Tablet ER:
- Diarrhea
- Nausea
- Vomiting
- Flatulence
- Polyuria
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Hypoglycemia (low blood glucose level)
- Conjunctivitis
- Cough
How to use Sita-Glutaryl DM Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. The tablet should be swallowed whole; avoid crushing, chewing, or breaking it. Sita-Glutaryl DM Tablet ER can be consumed with or without food, although consistent timing is recommended.
How Sita-Glutaryl DM Tablet ER works:
Sita-Glutaryl DM Extended-Release tablets combine three antidiabetic agents. Dapagliflozin works by enhancing glucose elimination via the urine, thereby lowering blood sugar. Metformin acts on multiple fronts: reducing glucose absorption from ingested food, suppressing hepatic glucose production, and augmenting the body's sensitivity to insulin—a hormone regulating blood glucose. Sitagliptin manages blood glucose by boosting incretin levels, prompting the pancreas to secrete more insulin and inhibiting excessive glucose synthesis by the liver.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Consuming alcohol while taking Sita-Glutaryl DM Tablet ER may be unsafe; seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Data on Sita-Glutaryl DM Tablet ER use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Sita-Glutaryl DM Tablet ER with breastfeeding are lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Sita-Glutaryl DM Tablet ER on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Sita-Glutaryl DM Tablet ER in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Sita-Glutaryl DM Tablet ER in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Sita-Glutaryl DM Tablet ER :
NA
Facts to Know About Sita-Glutaryl DM Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
